Atlas Trials

PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects

Clinical trial NCT06332638 · UNKNOWN

Trial details

NCT number
NCT06332638
Sponsor
HK inno.N Corporation
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2024-03-19
Primary completion
2024-07-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.